RSVAX Mutual Fund

NAV$27.25

Fund Essentials - as of Mar 31, 2026

Net Assets
$147M
Expense Ratio
1.30%
Dividend Yield (Current)
8.19%
Holdings
58
Inception Date
Jun 30, 1993
Fund Family
Victory Capital Management Inc.
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually
SEC 30-Day Yield
PRO

Performance

YTD+7.09%
1 Year+20.10%
3 Year+12.31%
5 Year+8.80%
10 Year+10.13%

Asset Allocation

Stocks: 98.32%
Other: 1.68%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
GLGlobe Life Inc.3.66%
MKTXMarketaxess Holdings Inc. Com Usd0.0033.46%
FEFirstenergy Corp.3.00%
TEVA:TLTeva Pharmaceutical Industries Ltd. (ADR)2.81%
TKRTimken Co2.76%
Top 10 Concentration: 28.10%Report Date: Mar 31, 2026
Download all 58 holdings for RSVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
8.19%
Frequency
Annually
Latest Distribution
$0.11
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how RSVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$99/yr
7-day refund. Cancel anytime.
X-ray my whole portfolio
$99/yr Pro · 7-day refund. From MarketXLS, trusted since 2014.

RSVAX Mutual Fund Overview

RSVAX Mutual Fund (Victory RS Value Fund Class A) is managed by Victory Capital Management Inc. with $147.0M in net assets. RSVAX expense ratio is 1.30%, holding 58 positions across sectors including Industrials, Financials, Health Care. Inception date: 1993-06-30.

RSVAX performance shows a YTD return of 7.09%. The 1-year return is 20.10% and the 5-year return is 8.80%. RSVAX dividend yield stands at 8.19%, paid annually.

RSVAX top holdings include Globe Life Inc. (3.7%), Marketaxess Holdings Inc. Com Usd0.003 (3.5%), Firstenergy Corp. (3.0%), Teva Pharmaceutical Industries Ltd. (ADR) (2.8%), Timken Co (2.8%). View all RSVAX holdings, sector breakdown, or dividend history.

RSVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. RSVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.